Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'.

Perricone, Carlo; Bartoloni, Elena; Cafaro, Giacomo; Caporali, Roberto; Gerli, Roberto

Perricone, Carlo; Bartoloni, Elena; Cafaro, Giacomo; Caporali, Roberto; Gerli, Roberto.

Afiliação

Perricone C; Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Bartoloni E; Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Cafaro G; Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Caporali R; Department of Clinical Sciences and Community Health, ASS G Pini, University of Milan, Milano, Italy.
Gerli R; Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy roberto.gerli@unipg.it.

Ann Rheum Dis ; 82(4): e81, 2023 04.

Article em En | MEDLINE | ID: mdl-33509794

Assuntos

COVID-19; Gota; Humanos; Colchicina/uso terapêutico; Supressores da Gota/uso terapêutico; Gota/tratamento farmacológico; Anti-Inflamatórios/uso terapêutico

Palavras-chave

Covid-19; gout; inflammation

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Gota Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google